4Wagsiiter D, Zhu C, Bjerkegren J, et al. MMP-2 and MMP-9 are prominent matrix metalloproteinases during atherosclerosis development in the Ldlr( -/- )Apob( 100/100) mouse[J]. Int J Mol Med,2011,28 (2):247-253. 被引量：1
5Phipps JE, Hatami N, Galis ZS. A fluorescence lifetime spectroscopy study of matrix metal1oproteinases-2 and -9 in human atherosclerotic plague[J]. J Biophotonics,2011,4(9):650-658. 被引量：1
6Heo SH, Cho CH, Kim HO. Plaque rupture is a determinant of vascular events in carotid artery atherosclerotic disease: involvement of matrix metalloproteinases 2 and 9[J]. J Clin Neurol,2011 ,7(2):69-76. 被引量：1
7Shevchenko AV, Golovanova OV, Konenkov VI. Analysis of the gene polymorphism of matrix metalloproteinase-2 and -9 in patients with coronary heart disease[J]. Ter Arkh,2010,82(1):3l-34. 被引量：1
8Braunersreuther V, Steffens S, Arnaud C. A novel RANTES antagonist prevents progression of established atherosclerotic lesions in mice[J]. Arterioscler Thromb Vase Biol,2008,28(6): 1090-1096. 被引量：1
9Packard RR, Libby P. Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction [J]. Clin Chem, 2008,54(1):24-38. 被引量：1
10Chen KC, Wang YS, Hu CY, et al. OxLDL up-regulates microRNA- 29b, leading to epigenetic modifications of MMP-21 MMP-9 genes: a novel mechanism for cardiovascular diseases [J]. FASEB J,2011,25 (5): 1718-1728. 被引量：1
